These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3891080

  • 1. Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.
    Danks MK, Metzger DW, Ashmun RA, Beck WT.
    Cancer Res; 1985 Jul; 45(7):3220-4. PubMed ID: 3891080
    [Abstract] [Full Text] [Related]

  • 2. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differentiation and the multiple drug resistance phenotype in human leukemic cells.
    Beck WT, Cirtain MC, Ashmun RA, Mirro J.
    Cancer Res; 1986 Sep; 46(9):4571-5. PubMed ID: 3015390
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
    Beck WT.
    Cancer Treat Rep; 1983 Oct; 67(10):875-82. PubMed ID: 6354435
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.
    Beck WT, Mueller TJ, Tanzer LR.
    Cancer Res; 1979 Jun; 39(6 Pt 1):2070-6. PubMed ID: 571759
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cross and non-cross resistant anticancer agents to multidrug-resistant cultured cells from hematologic malignancies].
    Shimoyama M, Ishida Y, Ohtsu T, Shimada Y, Tobinai K, Minato K.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1273-9. PubMed ID: 2730025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.